Clinical trials
Phase 1 COVID-19 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 14 |
| 2021 | 8 |
| 2022 | 18 |
| 2023 | 14 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 21 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brii Biosciences Limited | 3 |
| Guangzhou Patronus Biotech Co., Ltd. | 3 |
| Livzon Pharmaceutical Group Inc. | 3 |
| Zhejiang ACEA Pharmaceutical Co. Ltd. | 3 |
| Ascletis Pharmaceuticals Co., Ltd. | 2 |
| CanSino Biologics Inc. | 2 |
| Frontier Biotechnologies Inc. | 2 |
| Heronova Pharmaceuticals | 2 |
| Huahui Health | 2 |
| Jiangsu Province Centers for Disease Control and Prevention | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 57 |
| Coronavirus Infections | 3 |
| Chronic Cough | 1 |
| Immunologic Deficiency Syndromes | 1 |
| Infections | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.